Tuesday, March 2, 2021
Home Business Maybe too soon to rule out hydroxychloroquine; tricking the immune system

Maybe too soon to rule out hydroxychloroquine; tricking the immune system


© Reuters. The drug hydroxychloroquine, pushed by U.S. President Donald Trump and others in recent months as a possible treatment to people infected with the coronavirus disease (COVID-19), is displayed in Provo

By Nancy Lapid

(Reuters) – The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.

Combining trial data suggests hydroxychloroquine benefit

In a series of randomized controlled trials, the malaria drug hydroxychloroquine did not show a statistically significant impact on the prevention or treatment of COVID-19. But when data from five of those trials were combined, researchers found that early use of the drug by people who were not hospitalized yielded a statistically significant 24% reduction in risk of infection, hospitalization or death. “The meta-analysis pools together the studies and increases statistical power,” said Dr. Joseph Ladapo of the David Geffen School of Medicine at UCLA, coauthor of a report posted on Wednesday on medRxiv ahead of peer review. But a weakness of the meta-analysis, Ladapo acknowledged, is that infections, hospitalizations and deaths were grouped together into a “composite outcome.” Combining all those events into one big number makes it more likely researchers will find that treatment had a significant effect. Coauthor Dr. Harvey Risch of the Yale School of Public Health noted that seven nonrandomized controlled trials have also shown “statistically significant reduced risks with early outpatient use of hydroxychloroquine.” Along with the meta-analysis, he told Reuters, “This is extremely strong evidence of benefit.” (https://

COVID-19 tricks body into attacking blood-clotting proteins

The excessive blood clotting seen in severe COVID-19 may in part be caused by the virus tricking the body into attacking itself. In patients with severe cases of the virus, the immune system produces high levels of a type of antibody that mistakenly attacks important proteins called phospholipids, which help keep blood from clotting, researchers say. In a study of 64 COVID-19 patients published on Wednesday in Clinical Infectious Diseases, those with severe disease consistently had more antiphospholipid antibodies than those with mild disease, regardless of gender or age. “Our data strongly suggest that when our body fights the new coronavirus in our lungs, it also starts to fight its own proteins that keep our blood from clotting,” coauthor Dr. Omar Hasan Ali of The University of British Columbia told Reuters. This problem has been seen before, in a rare autoimmune disease called antiphospholipid syndrome that is usually triggered by infections. (https://

CPR usually unsuccessful for COVID-19 cardiac arrests

Cardiac arrests are common among critically ill COVID-19 patients but cardiopulmonary resuscitation (CPR) is usually unsuccessful. On Monday in JAMA Internal Medicine, Michigan doctors reported that among 54 hospitalized COVID-19 patients who suffered cardiac arrests, none survived. A separate study published on Wednesday in The BMJ found that among 701 COVID-19 patients who had cardiac arrests, CPR was attempted in slightly more than half; the others had “do not resuscitate” orders in place. Only 48 cardiac arrest patients left the hospital alive, and only 28 did so with normal or mildly impaired brain function. Survival odds were the lowest for older patients and for patients whose heart could not be quickly restarted. Most arrests involved “unshockable rhythms,” which means the heart cannot respond to electric shocks from a defibrillator. Dr. Dilip Khanal of Beaumont Health System, coauthor of the Michigan study, told Reuters, “While it is not possible to make blanket recommendations … this type of information should help patients and family to make informed choices” about whether to attempt CPR for a cardiac arrest. His team said research is needed to determine the benefit of prolonged CPR efforts on COVID-19 patients who are not responding, given that the process “generates aerosols that may place health care personnel at a higher risk of contracting the virus.” (https:// https://

Open https://tmsnrt.rs/3a5EyDh in an external browser for a Reuters graphic on vaccines and treatments in development.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.





Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular

A Critic of Technology Turns Her Gaze Inward

In the spring of 1977, when Sherry Turkle was a young professor at the Massachusetts Institute of Technology, Steve Jobs came to visit....

Cheque dishonor cases can’t be filed or continued against firms facing insolvency proceedings: SC

The Supreme Court Monday held the cheque bounce cases can neither be instituted nor be continued against companies which are facing insolvency proceedings...

Oppo Find X3 Pro launch date officially set for March 11

Oppo has sent a press release, confirming the launch date for its Find X3 Pro flagship. It will arrive on March 11 at...

Far-Right Platform Gab Has Been Hacked—Including Private Data

When Twitter banned Donald Trump and a slew of other far-right users in January, many of them became digital refugees, migrating to...

Recent Comments

Close Bitnami banner